Major Advance in Omega 3 Fish Oil Products
Updated Dec. 30, 2010
about 9 years ago
Vectomega is the first major advance in omega 3 science in the last 30 years. The unique processes utilized in creating this product allow for the highest level of EPA and DHA absorption available in a natural nutritional whole foods supplement.
The omega 3 fatty acids from salmon in Vectomega have intracellular absorption rates 50 times greater than fish oils. Two tablets once per day is all you will need to acheive the desired therapeutic doseage. Additionally, due to the purity and stability of Vectomega tablets, there will never be a problem with stomach upset or distasteful "fish burps."
Vectomega is approximately 60 to 90 calories per month, because it is not an oil and not bound to triglycerides. The calories from fish oil can add up to anywhere from 1000 to 2000 calories per month. What a difference Vecotmega can make to your health!
Benefits of the revolutionary Vectomega
- Unaltered Nature-Identical Omega-3 from Salmon - without the oil and minus the calories!
- Nominated "BEST NEW PRODUCT" - NutrAward 2010
- Absorbed up to 50 times greater than triglyceride fish oils
- Omega-3 fatty acids clinically studied for healthy heart, brain, skin, immune and nervous system support
- Extracted by a patented chemical-free process using only natural enzymes and a cold water flush
- Exceeds both European and U.S. standards for purity – no concerns with toxins or contaminants
- Sustainably harvested in salmon’s natural environment
- One tablet provides the Omega-3 DHA/EPA benefits equivalent to 4-6 grams of fish oil or 6-8 ounces of salmon
- Never any Fish Burps or Fishy After-taste
VECTOMEGA, in the correct dosage, through its optimal bioavailability and its respect for cellular physiology, is destined to hold a prime position in the fight against aging.
IS YOUR FISH OIL SUPPLEMENT REALLY NATURAL?
Vectomega isn’t like other products. Fish oils are generally extracted from small, cold-water pelagic fish, such as the sardine, anchovy, capelin, herring and menhaden, containing high proportions of EPA and DHA. The fish then undergo “cooking and pressing” steps, using a thermal treatment of the raw material at temperatures close to boiling and causingcoagulation of the proteins. This concentration process requires large quantities of solvents and chemical products (soda, hexane and methanol) and generates a huge amount of
toxic waste that needs to be reprocessed.
However, when fish oil is processed and refined using this method, this results in a random redistribution of fatty acids, generally increasing the amount of unsaturated
fatty acids at the sn-1/sn-3 (terminal) positions of the carbon chain. In contrast, Vectomega uses a patented innovation, called vectorization, uses a gentle, cold-water and enzyme
process avoiding heat, solvents, and chemical modifications that are utilized to process all other fish oils.
The enzyme vectorization of Vectomega has no effect on the oil’s natural sn-2 carbon position. This is significant because when DHA or EPA fatty acids are attached to the glycerol in
mid position (sn-2) the molecule is more stable, less prone to oxidation, and far better absorbed than those attached to the terminal position sn-1 or sn-3.
Omega-3 oil’s sn-2 position is also significant in regard to bioabsorption. Clinical studies have shown that the composition and position of fatty acids affects both bioavailability and
digestibility of fats and oils in infants as well as adults. For example, one study I reviewed has concluded that fatty acids from breast milk and formula milk with palmitic fatty acid in the
sn-2 position were better absorbed than fat with sn-1,-3 palmitic acid from palm oil. The same holds for the all-important Omega-3s, too.
In fact, Vectomega’s phospholipid vectorization has been clinically demonstrated to have superior bioavailability compared to fish oils. Research has shown that because the marine
phospholipids contain DHA and EPA in a specific and optimal location on the carbon chain, Vectomega is up to 50 times more absorbable via cell membranes.
HEALTH BENEFITS DIRECTLY ATTRIBUTED TO VECTOMEGA
The experimental and clinical research that documents the potential benefits for Alzheimer’s disease prevention and for maintaining normal healthy cholesterol and triglyceride levels
is most impressive. Especially how Vectomega is shown to significantly raise levels of the good high-density lipoproteins (HDL) cholesterol.
In a recent in vitro study published in the Journal of Neurochemistry, researchers pre-treated rat neuronal cells with Vectomega’s DHA for 48 hours before exposing these cells to
soluble oligomers of amyloidbetapeptide, which are known to cause the neurodegeneration associated with Alzheimer’s.
The study concluded that DHA pretreatment was observed to significantly increase neuronal survival upon amyloidbeta exposure
by preventing cytoskeleton perturbations, caspase activation and apoptosis, as well as by promoting extracellular signal-related, kinase-related survival pathways. Such
neuro-protective effects could be of major interest in the prevention of Alzheimer’s and other neurodegenerative diseases.
As for cardiovascular health, in a human open clinical trial just concluded in Europe, 40 healthy subjects took two Vectomega tablets per day (providing 32.8 mg DHA and 10.4 mg of
EPA per two tablets) without any modifications to diet or exercise habits. After 60 days, the subjects experienced a 16 percent decrease in triglycerides, a 10 percent decrease in
total cholesterol, and a 13 percent increase in HDL levels.
Vectomega is a safe and pure product, which exceeds all government guideline levels for safety. Heavy metal analysis is conducted on every batch using ICP-MS method.
Heavy Metal Analysis Method: ICP-MS
Arsenic (As) Complies
Beryllium (Be) Complies
Cadmium (Cd) Complies
Lead (Pb) Complies
Mercury (Hg) Complies
Nickel (Ni) Complies
GREEN BAY, January 15, 2010—Each year, leaders in the health and nutrition industry gather at the Nutracon conference and SupplyExpo in Anaheim, California, to recognize and
award the top new products at the forefront of ingredient and technology innovation. For 2010, New Hope Natural Media has announced Vectomega® by EuroPharma® as one of
three finalists for the inaugural NutrAward for Best New Finished Product containing a functional ingredient.
“Each year, thousands of new products are introduced to the natural products marketplace, and it is indeed an honor for Vectomega to be recognized as one of the three best in the
industry,” said Terry Lemerond, founder and president of EuroPharma, Inc.
“Vectomega represents the first major advance in omega 3 science in the last 30 years. The unique processes used to create this product achieve an unprecedented level of EPA
and DHA absorption. Only one to two tablets is required per day for therapeutic effect,” he explained.
According to Lemerond, omega 3 fatty acids in Vectomega show intracellular absorption rates up to 50 times greater than fish oils. In a clinical study of 40 healthy subjects who took
two Vectomega tablets daily, after 60 days they experienced a 16 percent decrease in triglycerides, a 10 percent decrease in total cholesterol, and a 13 percent increase in HDL
levels. In fish oil studies, 4 grams or more of fish oil daily were required to achieve similar results.